Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7373550rdf:typepubmed:Citationlld:pubmed
pubmed-article:7373550lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:7373550lifeskim:mentionsumls-concept:C0699900lld:lifeskim
pubmed-article:7373550lifeskim:mentionsumls-concept:C0243125lld:lifeskim
pubmed-article:7373550lifeskim:mentionsumls-concept:C1514468lld:lifeskim
pubmed-article:7373550lifeskim:mentionsumls-concept:C0524527lld:lifeskim
pubmed-article:7373550lifeskim:mentionsumls-concept:C0309782lld:lifeskim
pubmed-article:7373550lifeskim:mentionsumls-concept:C0309781lld:lifeskim
pubmed-article:7373550pubmed:issue4lld:pubmed
pubmed-article:7373550pubmed:dateCreated1980-7-22lld:pubmed
pubmed-article:7373550pubmed:abstractTextTwo previously reported but unidentified phenylburazone degradation products were isolated from a tablet that was stored at 60 degrees for 203 days. The compounds, alpha-(N-phenylcarbamoyl)-N-caproylhydrazobenzene and alpha-hydroxy-alpha-(N-phenylcarbamoyl)-N-caproylhydrazobenzene, were isolated by chromatography, identified by mass and NMR spectrometry, and synthesized by the reaction of aniline with phenylbutazone or its hydroxy analog, respectively.lld:pubmed
pubmed-article:7373550pubmed:languageenglld:pubmed
pubmed-article:7373550pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7373550pubmed:citationSubsetIMlld:pubmed
pubmed-article:7373550pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7373550pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7373550pubmed:statusMEDLINElld:pubmed
pubmed-article:7373550pubmed:monthAprlld:pubmed
pubmed-article:7373550pubmed:issn0022-3549lld:pubmed
pubmed-article:7373550pubmed:authorpubmed-author:LoveringE GEGlld:pubmed
pubmed-article:7373550pubmed:authorpubmed-author:RobertsonD...lld:pubmed
pubmed-article:7373550pubmed:authorpubmed-author:PoirierM AMAlld:pubmed
pubmed-article:7373550pubmed:authorpubmed-author:MatsuiFFlld:pubmed
pubmed-article:7373550pubmed:issnTypePrintlld:pubmed
pubmed-article:7373550pubmed:volume69lld:pubmed
pubmed-article:7373550pubmed:ownerNLMlld:pubmed
pubmed-article:7373550pubmed:authorsCompleteYlld:pubmed
pubmed-article:7373550pubmed:pagination469-71lld:pubmed
pubmed-article:7373550pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:7373550pubmed:meshHeadingpubmed-meshheading:7373550-...lld:pubmed
pubmed-article:7373550pubmed:meshHeadingpubmed-meshheading:7373550-...lld:pubmed
pubmed-article:7373550pubmed:meshHeadingpubmed-meshheading:7373550-...lld:pubmed
pubmed-article:7373550pubmed:meshHeadingpubmed-meshheading:7373550-...lld:pubmed
pubmed-article:7373550pubmed:meshHeadingpubmed-meshheading:7373550-...lld:pubmed
pubmed-article:7373550pubmed:meshHeadingpubmed-meshheading:7373550-...lld:pubmed
pubmed-article:7373550pubmed:year1980lld:pubmed
pubmed-article:7373550pubmed:articleTitleIdentification of degradation products in a phenylbutazone tablet formulation.lld:pubmed
pubmed-article:7373550pubmed:publicationTypeJournal Articlelld:pubmed